Compare MIRA & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIRA | SVRE |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 1.5M |
| IPO Year | 2023 | 2022 |
| Metric | MIRA | SVRE |
|---|---|---|
| Price | $1.50 | $1.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 254.9K | ★ 376.2K |
| Earning Date | 11-13-2025 | 12-21-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $580,536.00 |
| Revenue This Year | N/A | $453.30 |
| Revenue Next Year | N/A | $106.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.19 |
| 52 Week Low | $0.73 | $1.21 |
| 52 Week High | $2.45 | $132.00 |
| Indicator | MIRA | SVRE |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 45.68 |
| Support Level | $1.52 | $1.21 |
| Resistance Level | $1.69 | $1.45 |
| Average True Range (ATR) | 0.08 | 0.30 |
| MACD | -0.00 | -0.11 |
| Stochastic Oscillator | 24.00 | 5.97 |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road and pedestrians. Geographially, it operates in Israel and Europe, out of which it derives maximum revenue from Israel.